Clinical trial
A Study of ADH-1 in Combination With Normothermic Isolated Limb Infusion of…
NCT00421811 · Adherex Technologies, Inc., Industry · Completed
Key facts
| NCT number | NCT00421811 |
|---|---|
| Title | A Study of ADH-1 in Combination With Normothermic Isolated Limb Infusion of Melphalan |
| Official title | An Open-Label, Multicenter, Phase 1/2 Dose Escalation Study to Evaluate Safety, Tolerability and Anti-tumor Activity of Systemic ADH-1 in Combination With Normothermic Isolated Limb Infusion of Melphalan in Subjects With Locally Advanced In-Transit Malignant Melanoma (Adherex Protocol Number… |
| Lead sponsor | Adherex Technologies, Inc., Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Neoplasms |
| Intervention type | Drug |
| Interventions | ADH-1, melphalan |
| Enrollment | 56 |
| Start date | Apr 1, 2007 |
| Primary completion | Mar 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Jan 12, 2007 |
| Last update posted | Dec 28, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: